All News

Topics like cybersecurity are always top of mind at health information technology meetings, but other topics, such as artificial intelligence, also grabbed people’s interest at HIMSS 2017.

This week, the top managed care stories included Republicans releasing an outline for replacing the Affordable Care Act, pharmacy benefit managers and pharmaceutical companies pointing fingers over drug costs, and findings on engagement for patients with chronic conditions.

The shift is almost entirely due to a boost of support from independents. Respondents also overwhelmingly support keeping funds for Medicaid expansion.

Patients treated by primary care providers with a high volume of patients experienced worse management of their disease. However, if a physician specifically treated a higher number of diabetics, the quality of the diabetes care received by patients was significantly higher.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Using body composition metrics to guide the dose in patients receiving anthracyclines-taxane—based chemotherapy for breast cancer can reduce treatment-related toxicity.

The FDA has approved lenalidomide as maintenance therapy in patients with multiple myeloma following autologous stem cell transplant.

The results are important given the concentration of Medicare beneficiaries who are in Medicaid and being treated for multiple chronic conditions.

Amgen and Harvard Pilgrim Healthcare have entered an outcomes-based contract that is based on the efficacy of Amgen’s immunomodulatory agent etanercept (Enbrel), for patients with rheumatoid arthritis.

The study adds to the growing body of evidence linking heart disease and diabetes to dementia.

While many questions on the outlook of healthcare “re-reform” remain afloat, many important insights into President Donald Trump’s potential path forward are now identified.

Over 65,000 ineligible providers have been culled from the Medicaid program due to a component of the Affordable Care Act (ACA) that requires periodic recertification of eligibility.

The company's study has found a 38% drop in cigarette purchase among shoppers who visit CVS stores.

A recent literature review, examining evidence on lifestyle changes that can reduce the risk of recurrence or death for women diagnosed with breast cancer, found that exercise can reduce the risk of both outcomes.

A popular strategy to help stem the tide of opioid-related deaths has been the implementation of laws that expand access to naloxone, the drug that halts and reverses overdoses. A recent paper has found that these laws did in fact save lives.

The results from the United Kingdom support CMS' decision to add a payment code for collaborative care to this year's Medicare Physician Fee Schedule.

The results follow a separate report that outlined the reasons why low-income workers don't seek preventive care, and what can be done.

Researchers at the American Cancer Society have found that nonelderly cancer survivors enrolled in high-deductible health plans are more likely to seek a change to a lower-cost prescription medication compared with those without a cancer history.

Population-level judgements on the value of therapies to treat multiple sclerosis don’t adequately depict the differences between how providers and payers view value compared with patients and how patients view value different from one another.

Critical access hospitals in rural areas continue to be threatened by unsustainable operating costs, but a recent blog post on Health Affairs proposed an innovative solution to ensure access to care persists in these areas: freestanding emergency centers.

The announcements come as Medicare is set to start reimbursing the Diabetes Prevention Program on January 1, 2018.

Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor—positive early-stage breast cancer.

Here you can access pages highlighted in our Instagram feed.

Two surveys, one each for patients and providers, reveal gaps between patient confidence to manage disease or pain and what they'd like to see from their physicians.

Adverse events from cancer clinical trials are currently reported by trial investigators, but a recent feasibility study found that patients can successfully and accurately report their own symptoms if given the opportunity.

New research indicates that Medicare patients were more likely to continue using opioid painkillers a year after a visit to the emergency department if they had been treated there by a physician that frequently prescribes opioids.